WO2003015701A2 - Lipobeads and their production - Google Patents
Lipobeads and their production Download PDFInfo
- Publication number
- WO2003015701A2 WO2003015701A2 PCT/US2002/026056 US0226056W WO03015701A2 WO 2003015701 A2 WO2003015701 A2 WO 2003015701A2 US 0226056 W US0226056 W US 0226056W WO 03015701 A2 WO03015701 A2 WO 03015701A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- glycero
- poly
- phosphatidylcholine
- lipobeads
- approximately
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1273—Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
- Y10T428/2985—Solid-walled microcapsule from synthetic polymer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
- Y10T428/2985—Solid-walled microcapsule from synthetic polymer
- Y10T428/2987—Addition polymer from unsaturated monomers only
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2989—Microcapsule with solid core [includes liposome]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2991—Coated
Definitions
- the present invention concerns nanogels encapsulated within a lipid bilayer (lipobeads) and their production.
- Liposomes are phospholipid assemblies consisting of a flexible, cell membrane-like lipid bilayer, the surface of which acts as a permeability barrier. Different compounds can be entrapped in the liposome's aqueous interior. It has been shown that liposomes can be constructed with bilayer permeability responsive to a variety of physical and chemical stimuli, including temperature, light, pH, and ions (See, e.g., G. Gregoriadis et al., Vesicles. Marcel Dekker: New York (1996). This book is incorporated herein by reference.). These liposomes can mimic various functions of biological membranes and can be used as a container for storage, transport, and controllable release of compounds. Liposomes can be mechanically unstable, however and their loading capacity is limited by the water solubility of the material to be loaded.
- Hydrogel particles are mechanically more stable than liposomes because of cross-linking and have larger loading capacities than liposomes. Their properties (swelling/de-swelling) can be more sensitive to environmental conditions. It has been reported that some polymer gels can swell or shrink discontinuously and reversibly in response to many different stimuli (temperature, pH, ions, electric fields or light) depending on the chemical composition of the gel/solvent system. The volume change can be as large as a thousand-fold. Macroscopic gels respond to the environmental changes on a rather long-time scale, however. (See, e.g., the article Tanaka et al., J Chem. Phys.. 90: 5161 (1989).
- hydrogels lack many useful surface properties of a lipid bilayer.
- Lipid bilayers stabilized on various supports See, e.g., the articles: Bayer et al., Biophvs. J. 58: 357 (1990); Rothe et al., EERS. Eett.. 263: 308 (1990); Plant, Lansmuir. 9: 2764 (1993); Spinke et al, Biophvs. J.. 63: 1667 (1992). These articles are incorporated herein by reference.) have found a number of applications (See, e.g., the articles: Sackman, Science.
- Bilayer membranes on solid supports are attractive systems mimicking the structural, sensing, and transport roles of biological membranes (See, e.g., the articles: Woodhouse et al., Faraday Discuss. Ill: 247 (1998); Wagner et al., Biophvs. J.. 79: 1400 (2000); Raguse et al., Lansmuir, 14: 648 (1998); Cornell et al., Nature. 387: 580 (1997); Kasianowicz et al., Anal. Chem.. 73: 2268 (2001).
- hydrogel-liposome assemblies combine the properties of both classes of materials, which broaden their potentials for biomimetic sensory systems, controlled release devices, and multivalent receptors.
- Encapsulating hydrogel particles in liposomes was described (See, e.g., the article, Gao, K.; Huang L. Biochim. Biophvs. Ada. 897: 377 (1987), hereafter referred to as "the Gao article”. This article is incorporated herein by reference.). Although the overall mechanical strength of the liposomal structure discussed in the Gao article was enhanced in the latter system, the unanchored bilayer was still unstable and needed specific lipid mixtures and polymer cores of certain sizes and shapes. The article by Jin et al. (FEBSLett. 397: 70 (1996).
- This article is incorporated herein by reference.) reported the design and preparation of a novel hydrogel- anchored lipid vesicle system, named "lipobeads".
- This system contained (i) a hydrogel polymer core anchored by fatty acids, which were covalently attached to the surface of the hydrogel and (ii) a lipid monolayer around the modified hydrogel spherical particle.
- the bilayer consisting of hydrophobic chains of fatty acids and hydrophobic tails of the phospholipids, was more stable than that in the system discussed in the Gao article.
- Spherical anionic microgels (6.5 ⁇ m at pH 7.0), composed of methylene-bw-acrylamide and methacrylic acid and loaded with doxorubicin, were coated with a lipid bilayer (See Kiser et al., Nature, 394: 459 (1998). This article is incorporated herein by reference.) to control swelling and release of doxorubicin from the microgels. (See, e.g., the article Yang et al., J Chromotosr. B. 707: 131 (1998). This article is incorporated herein by reference.) Biotinylated small and large unilamellar liposomes were immobilized in avidin- or streptavidin-derived gel beads for chromatographic analysis.
- hydrogel/liposome systems that can respond to changes in the environment on a short time scale are needed.
- the present invention describes preparing and characterizing hydrogel nanoparticles (nanogels) and liposomes.
- the present invention also describes different assemblies of nanogels and liposomes defining various hydrogel/liposome systems. These hydrogel liposome systems will often combine complementary advantages of the liposomes and the polymeric hydrogels. Studying the individual behavior of the hydrogel particles and liposomes in aqueous solution affords better understanding of the behavior of the hydrogel/liposome system.
- the following systems were prepared and characterized: (i) an unanchored nanogel entrapped in a liposome; (ii) an anchored nanogel entrapped in a liposome; (iii) an aggregate of unanchored nanogels coated with phospholipid bilayer ("giant" lipobeads), (iv) an aggregate of anchored nanogels coated with phospholipid bilayer ("giant” lipobeads), (v) an aggregate of anchored and unanchored nanogels coated with phospholipid bilayer (combined giant lipobeads) and (vi) an aggregate of anchored lipobeads.
- the present invention also describes the size distribution changes of the hydrogel particles, liposomes, and their assemblies in response to solvent variations, temperature variations, pH variations, and ionic strength variations.
- Figure 1 is a scheme depicting lipobead preparation by polymerizing hydrogel-forming components within liposomes.
- Figure 2 is a scheme depicting lipobead preparation by constructing liposomes and nanogels independently and then mixing them together.
- Figure 3 shows graphs of the size distribution curves for (a) liposomes, (b) pure PNIPA nanogels, and their mixture below (c) and above (d) the volume phase transition temperature.
- Figure 4 shows graphs of the size distribution curves for (a) liposomes, (b) anchored PNDPA-NI nanogels, and their mixture (c) below and (d) above the volume phase transition temperature.
- AFM Atomic Force Microscopy
- Figures 6a and 6b are AFM images (amplitude data) of (a) a PNDPA-NI lipobead after gelation inside liposomes (frame 400x400 nm 2 ; 1, flattened lipid bilayer; 2, nanogel); and (b) mixed phospholipid/detergent micelles and a nanogel after lipid bilayer solubilization (frame 440x440 nm 2 ; 1, nanogel; 2, mixed micelles).
- Figure 7 shows graphs of the size distribution curves for (a) P ⁇ TPA-NI lipobeads in buffer (pH 7.5) and after addition of 15 mM T x-100 at (b) pH 7.5 and (c) pH 2.5.
- Figure 8 shows a graph of the size distribution curve for PAAm lipobeads in buffer.
- Figures 9a and 9b are (a) an AFM images (amplitude data) of giant lipobeads produced by long-term aging of a mixture of EPC liposomes and PNJPA-NI nanogels after tliree months (frame 10x10 ⁇ m 2 ) and (b) a schematic presentation of the giant lipobeads formation in aging.
- Figure 10 shows graphs of (a) the Z-average diameter of liposomes as a function of temperature during heating/cooling cycles and (b) pH Dependence of the average diameter of the liposomes.
- Figure 11 shows graphs of the size distribution curves for the pure P ⁇ TPA hydrogel particles in water (a) below and (b) above the volume phase transition temperature.
- Figure 12 shows graphs of the size distribution curves for (a) P ⁇ IPA lipobeads in buffer at 25 °C, (b) after addition of 15 mM T x-100 at 25 °C, (c) at 35 °C, and (d) at 40 °C.
- Figure 13 is a table that lists the composition of hydrogel-forming media and properties of macroscopic hydrogels.
- Figure 14 is a graph of the Z-average diameter of anchored P ⁇ TPA-NI lipobeads (a) as a function of temperature upon heating/cooling cycles and (b) as a function of pH.
- Figure 15 includes graphs showing the effect of temperature on the collapse and subsequent aggregation of P ⁇ JPA-NI nanogels for pure P ⁇ TPA-NI nanogels in water at temperatures below, and at a temperature above, the volume phase transition temperature.
- Figure 16 is a graph showing the pH dependence of the average diameter of P ⁇ IPA-NI nanogels.
- the present invention concerns lipobeads, giant lipobeads, their production, and their properties.
- the present invention functions to produce assemblies of liposome-encapsulated nanogel particles that respond to environmental conditions such as pH, temperature, and ions on a fast time scale.
- Liposome preparation is described in U.S. Patent Application Serial No. , filed on August 14, 2002, entitled NANOGELS AND THEIR PRODUCTION USING LIPOSOMES AS REACTORS, by Sergey Kazakov, Marian Kaholek, and Kalle Levon (This patent is incorporated herein by reference).
- this technique of preparing liposomes involves freezing and thawing a solution of multilamellar vesicles (MLV) followed by sonication to yield large unilamellar vesicles (LUV) within the range of average sizes from 30 to 1000 nm.
- MLV multilamellar vesicles
- LUV large unilamellar vesicles
- this technique of preparing nanogels involves (i) encapsulating hydrogel-forming components into the liposomes and (ii) polymerizing the encapsulated hydrogel-forming components.
- the present invention may be used to produce lipobeads by (a) polymerizing hydrogel- forming components within liposomes, or (b) mixing nanogel particles with liposomes to form lipid bilayer-coated hydrogel particles.
- the first method prepares liposomes before gelation and then polymerizes hydrogel-forming components inside the liposomes, as shown in Figure 1.
- This method has the advantage of forming a more stable lipid bilayer.
- nanogels inside the liposomes are unable to undergo further modifying treatments such as loading, entrapment, or surface functionalization. Such procedures should be planned in the course of gelation instead.
- Lipobead fusion and formation of "giant" or combined lipobeads is impossible using this method. Polymerizing anchored or unanchored hydrogel-forming components within liposomes was described in U.S. Patent Application Serial No. , filed on August 14, 2002, entitled
- the second method prepares liposomes and nanogels independently, as shown in Figure 2.
- penetration by a nanogel into a liposome ruptures the liposome's lipid bilayer.
- the lipid bilayer on the surface of nanogels is strong and stable enough to mask the nanogels' sensitivity to changes in external conditions.
- the sensitivity of PNIPA- VI lipobeads to temperature and pH was masked due to their lipid bilayer coat (See Figure 11).
- the advantage of fabricating liposomes and nanogels independently is that nanogels can be loaded with different compartments, filled with different liquid media, or/and functionalized with specific ligands before they are coated by a lipid bilayer. Using this method, lipobeads may fuse to form giant lipobeads.
- lipobeads may be prepared by adding a liposome suspension to a solution of unanchored or anchored hydrogel particles. Incubating this solution for 1 to 4 hours at a temperature above the phase transition temperature of the phospholipid (Phospholipids' phase transition temperatures typically range from approximately -16 to +74 °C.
- Phospholipids' phase transition temperatures typically range from approximately -16 to +74 °C.
- unanchored poly(N- isopropylacrylamide) (PNIPA) hydrogel particles formed from 5-10 wt. % hydrogel-forming components
- liposomes formed from 5-10 mg/mL phospholipid in water or buffer
- Figures 3a and 3b show the size distribution curves for the pure liposomes and pure PNTPA nanogels with approximately the same average diameter of approximately 180 nm. Adding liposomes to the suspension of pure PNTPA nanogels and observing the sizes of the resulting structures allows one to determine if lipobeads form or if the particles remain separated. If both particles existed independently without interactions, one could expect that upon increasing temperature the hydrogel particles would shrink, whereas liposomal sizes would not change, and two separate peaks would be detected. If both particles formed aggregates, however, the resulting particles should be at least twice their initial average size, as was seen in Figures 14d and 13b.
- anchored PNTPA- VI lipobeads were generated by mixing PNTPA- VI nanogels (formed from 5- 15 wt. % hydrogel-forming components) with liposomes (formed from 5-10 mg/mL phospholipid in water or buffer) in a 1 : 1 ratio, incubating the mixture for 2 hours at room temperature and vortexing.
- FIGs 4a and 4b show the size distribution curves for liposomes and pure anchored PNIPA- VI nanogels with average diameters of approximately 160 nm, as was seen with PNTPA nanogels and liposomes (See Figure 3). Mixing the liposomes and the anchored PNTPA- VI nanogels resulted in lipobeads with the size distribution curve shown in Figure 4c. These three curves imply that the size distribution of the lipobeads is determined by the size distribution of the nanogels. Similar to mixing unanchored PNTPA nanogels and liposomes, each anchored PNTPA- VI hydrogel particle (1) is coated with a liposomes' phospholipid bilayer (2), forming a lipobead during mixing, as shown in Figure 5.
- USTNG LIPOSOMES AS REACTORS by Sergey Kazakov, Marian Kaholek, and Kalle Levon, generated anchored PNTPA- VI lipobeads.
- ODAm water-insoluble N-octadecylacrylamide
- PAAm poly(acrylamide) hydrogels
- Figure 8 shows a typical particle size distribution and structure of the lipobeads obtained after polymerization within liposomal microreactors.
- “Giant” lipobeads may be produced when lipobeads aggregate quickly due to collapsing the hydrogel particles or slowly due to long-term aging (See Figure 2). Combining liposomes with hydrogel particles to form lipobeads and providing the environmental conditions under which the hydrogel particles collapse and the lipobeads aggregate together produces giant lipobeads. Collapsing unanchored lipobeads and incubating for 1 to 4 hours at a temperature exceeding the volume phase transition temperature of the polymer results in the formation of lipid bilayer-coated hydrogel aggregates, or giant lipobeads.
- Anchored nanogels also may shrink inside liposomes due to temperatures above T v and partially aggregate, but the hydrophobic chains (anchors) on their surface stabilize the lipid bilayer and prevent fusion, thus prohibiting giant lipobeads from forming.
- lipobeads with anchored or unanchored nanogels may form giant lipobeads after long-term aging (2-3 months) at a temperature below the volume phase transition temperature of the polymer. (Lipobeads remain stable for approximately 1 month because the hydrogel stabilizes the lipid bilayer.) This method of producing giant lipobeads does not involve shrinking the nanogels inside the lipobeads.
- unanchored hydrogel particles are mixed with liposomes. Tncubating the mixture for 2 hours at a temperature above the volume phase transition temperature (32 °C for PNTPA nanogels) forms lipobeads. Heating to 40 °C causes the nanogels to collapse inside the lipobeads, reducing their total hydrophobic surface area and resulting in lipobead aggregation. After incubating the mixture for 20 minutes at elevated temperatures, the aggregated lipobeads' lipid bilayers fuse to yield giant lipobeads with a structure depicted in Figure 3d for PNTPA lipobeads.
- PNTPA and PNTPA-NI lipobeads aggregate and form giant lipobeads at room temperature (i.e., below volume phase transition temperature) without shrinking the nanogels inside the lipobeads. Aggregation and giant lipobeads formation occur over the course of long-term aging (2-3 months) of the lipobeads.
- An AFM image (amplitude data) of anchored P ⁇ TPA-NI giant lipobeads after three months storage at +4 °C is presented in Figure 9. ⁇ 4.2 PROPERTIES OF SYSTEMS GENERATED
- One goal of the present invention is to produce a system that mimics biological entities and responds quickly to changes in environmental conditions such as pH, ions, and temperature.
- Properties of liposomes and nanogels are described in ⁇ 4.2.1 and ⁇ 4.2.2, respectively.
- Properties of lipobeads and giant lipobeads are described in ⁇ 4.2.3 and ⁇ 4.2.4, respectively.
- FIG 10b shows the pH independence of the apparent diameter of EPC liposomes.
- liposomes were prepared at pH 7.5 (initial point, X); pH was increased by addition of 0.2 M ⁇ aOH (open circles) and decreased by addition of 0.1 M HC1 (solid circles). Since EPC is a neutral phospholipid, pH-responsive fusion of its lipid bilayer is not expected.
- DLS revealed a tendency of liposomes to aggregate at low pH (pH ⁇ 3), a result ascribed to possible protonation and neutralization of the P ⁇ - ⁇ " dipole in phosphocholine on the liposome interface and/or to destruction of the hydration shell including interfacial water molecules in close contact with lipid polar head-groups.
- PNTPA Poly(N-isopropylacrylamide)
- PNT A- VI poly(N-isopropylacrylamide-co-l- vinylimidazole) nanogels were characterized in terms of their response to changes in environmental conditions.
- properties of PNTPA and PNTPA- VI nanogels are described in ⁇ 4.2.2.1 and ⁇ 4.2.2.2, respectively.
- Lipobeads combine the properties of liposomes and the nanogels they enclose to create a system that is sensitive to changes in environmental conditions, hi the following, unanchored PNTPA lipobeads are described in ⁇ 4.2.3.1 and anchored PNTPA- VI lipobeads are described in ⁇ 4.2.3.2.
- PNTPA lipobeads were prepared as described in ⁇ 4.1.3.
- Figure 12a shows that a relatively broad size distribution of PNTPA lipobeads with a peak at around 250 nm are obtained after UN exposure of a diluted LUN suspension containing initial components of P ⁇ TPA gels (See Figure 13, line 3).
- Figure 12b demonstrates that again, addition of T ⁇ -100 in a molar ratio of 45:1 (detergent/lipid) results in two peaks with maxima at 9 nm and 250 nm ascribed to the mixed detergent-phospholipid micelles and the P ⁇ TPA hydrogel particles, respectively. The ratio between scattering intensities of small and large particles indicates that the concentration of nanogels is relatively low.
- the present invention can be used to produce lipobeads. Since such assemblies combine the properties of nanogels and liposomes, the present invention provides a system that can respond quickly to environmental changes and therefore opens up many new potential applications for lipobeads.
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02766006.7A EP1511580B1 (en) | 2001-08-16 | 2002-08-15 | Method for producing an anchored lipobead defined by a hydrogel |
AU2002329761A AU2002329761A1 (en) | 2001-08-16 | 2002-08-15 | Lipobeads and their production |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31287801P | 2001-08-16 | 2001-08-16 | |
US60/312,878 | 2001-08-16 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2003015701A2 true WO2003015701A2 (en) | 2003-02-27 |
WO2003015701A9 WO2003015701A9 (en) | 2003-04-24 |
WO2003015701A3 WO2003015701A3 (en) | 2004-12-29 |
Family
ID=23213406
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/026056 WO2003015701A2 (en) | 2001-08-16 | 2002-08-15 | Lipobeads and their production |
PCT/US2002/026055 WO2003015936A1 (en) | 2001-08-16 | 2002-08-15 | Nanogels and their production using liposomes as reactors |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/026055 WO2003015936A1 (en) | 2001-08-16 | 2002-08-15 | Nanogels and their production using liposomes as reactors |
Country Status (6)
Country | Link |
---|---|
US (3) | US7618565B2 (en) |
EP (2) | EP1425112B1 (en) |
AT (1) | ATE433744T1 (en) |
AU (1) | AU2002329761A1 (en) |
DE (1) | DE60232666D1 (en) |
WO (2) | WO2003015701A2 (en) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7618565B2 (en) * | 2001-08-16 | 2009-11-17 | Polytechnic Institute Of New York University | Lipobeads and their production |
US20040005352A1 (en) * | 2002-04-16 | 2004-01-08 | Lopez Gabriel P. | Biologically functionalized porous microspheres |
US20040185013A1 (en) * | 2003-01-30 | 2004-09-23 | Burgio Paul A. | Dental whitening compositions and methods |
US20040151691A1 (en) * | 2003-01-30 | 2004-08-05 | Oxman Joel D. | Hardenable thermally responsive compositions |
US7223826B2 (en) * | 2003-01-30 | 2007-05-29 | 3M Innovative Properties Company | Amide-functional polymers, compositions, and methods |
WO2004089434A1 (en) * | 2003-04-10 | 2004-10-21 | Teijin Limited | Biodegradable film having honeycomb structure |
US9233846B2 (en) * | 2005-10-14 | 2016-01-12 | The Regents Of The University Of California | Formation and encapsulation of molecular bilayer and monolayer membranes |
DE102006015271A1 (en) * | 2006-04-01 | 2007-10-11 | Lohmann & Rauscher Gmbh & Co. Kg | Biguanide-containing liposomes |
US8465981B2 (en) * | 2007-08-06 | 2013-06-18 | University Of Kentucky Research Foundation | Polypeptides, systems, and methods useful for detecting glucose |
US7959861B2 (en) * | 2007-09-19 | 2011-06-14 | Stc.Unm | Integrated affinity microcolumns and affinity capillary electrophoresis |
WO2009126442A1 (en) * | 2008-04-10 | 2009-10-15 | Board Of Regents, The University Of Texas System | Compositions and methods for composite nanoparticle hydrogels |
US9445975B2 (en) * | 2008-10-03 | 2016-09-20 | Access Business Group International, Llc | Composition and method for preparing stable unilamellar liposomal suspension |
CN102414258B (en) * | 2009-03-16 | 2014-03-26 | 陶氏环球技术有限责任公司 | A dispersion, and a process for producing the same |
EP2536819A4 (en) | 2010-02-16 | 2017-01-25 | The University of North Carolina At Chapel Hill | Array of micromolded structures for sorting adherent cells |
CN103167868B (en) * | 2010-10-14 | 2016-08-03 | 株式会社爱茉莉太平洋 | Hydrogel particle being coated with lipid and preparation method thereof |
US9150598B2 (en) | 2011-10-05 | 2015-10-06 | The Regents Of The University Of California | Masking apertures enabling automation and solution exchange in sessile bilayers |
GB201119032D0 (en) | 2011-11-03 | 2011-12-14 | Isis Innovation | Multisomes: encapsulated droplet networks |
EP3939572B1 (en) * | 2012-04-12 | 2024-03-27 | Yale University | Vehicles for controlled delivery of different pharmaceutical agents |
FR2993891B1 (en) * | 2012-07-27 | 2016-11-18 | Rhodia Operations | POLYMER COMPOSITION FOR INHIBITING THE FORMATION OF INORGANIC AND / OR ORGANIC DEPOSITS IN UNDERGROUND FORMATIONS |
GB201219201D0 (en) | 2012-10-25 | 2012-12-12 | Isis Innovation | Hydrogel network |
GB201219196D0 (en) | 2012-10-25 | 2012-12-12 | Isis Innovation | Droplet assembly method |
CN105188934B (en) | 2012-12-07 | 2018-12-04 | 牛津大学创新有限公司 | The drop component of 3D printing |
WO2014138278A1 (en) | 2013-03-05 | 2014-09-12 | The Regents Of The University Of California | Lipid bilayer coated mesoporous silica nanoparticles with a high loading capacity for one or more anticancer agents |
EP3399966B1 (en) | 2016-01-08 | 2023-03-29 | The Regents of the University of California | Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery |
CN105603437A (en) * | 2016-01-12 | 2016-05-25 | 北京科技大学 | Low-pH controllable-release intelligent corrosion inhibitor preparation method |
US10894956B2 (en) * | 2017-03-03 | 2021-01-19 | West Virginia University | Phospholipid nanogel for exoglycosidase enzyme stabilization |
GB2561157A (en) * | 2017-03-27 | 2018-10-10 | Univ Oxford Innovation Ltd | Compartmentalised gel matrix and method of production |
CN109942746B (en) * | 2019-03-27 | 2021-03-16 | 浙江理工大学 | Temperature-sensitive photoconductive valve and preparation method thereof |
CN110407980B (en) * | 2019-08-14 | 2021-12-14 | 中国林业科学研究院林产化学工业研究所 | Preparation method of cellulose high-molecular surfactant-based pH and temperature dual-response type composite hydrogel |
CN110655606B (en) * | 2019-10-22 | 2021-12-21 | 南京工程学院 | Method for preparing cationic polyacrylamide by composite photo-initiation |
IT202100002537A1 (en) * | 2021-02-05 | 2022-08-05 | Kyme Nanoimaging Srl | MICROFLUIDIC PROCESS FOR THE PREPARATION OF LIPOSOMAL NANOSTRUCTURES LOADED WITH HYDROGEL |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5464629A (en) | 1993-11-16 | 1995-11-07 | Georgetown University | Method of forming hydrogel particles having a controlled size using liposomes |
US6284375B1 (en) | 1996-10-18 | 2001-09-04 | Tuo Jin | Lipid vesicle system |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3277413D1 (en) * | 1981-07-15 | 1987-11-05 | Nippon Oil Co Ltd | Process for producing water-insoluble polymers of uniform shape |
US5314811A (en) * | 1992-07-13 | 1994-05-24 | Merck & Co., Inc. | Process for converting lipid-containing bacterial capsular polysaccharide into lipid-free polysaccharide |
US5573934A (en) * | 1992-04-20 | 1996-11-12 | Board Of Regents, The University Of Texas System | Gels for encapsulation of biological materials |
ATE247971T1 (en) * | 1995-08-01 | 2003-09-15 | Novartis Erfind Verwalt Gmbh | LIPOSOMAL OLIGONUCLEOTIDE COMPOSITIONS |
ATE238068T1 (en) * | 1996-07-01 | 2003-05-15 | Univ Utrecht | HYDROLYZABLE HYDROGELS FOR CONTROLLED RELEASE |
US6018033A (en) * | 1997-05-13 | 2000-01-25 | Purdue Research Foundation | Hydrophilic, hydrophobic, and thermoreversible saccharide gels and forms, and methods for producing same |
ES2243229T3 (en) * | 1999-02-03 | 2005-12-01 | Powderject Res Ltd | FORMULATIONS OF HYDROGEL PARTICLES. |
US7618565B2 (en) * | 2001-08-16 | 2009-11-17 | Polytechnic Institute Of New York University | Lipobeads and their production |
-
2002
- 2002-08-14 US US10/218,553 patent/US7618565B2/en not_active Expired - Fee Related
- 2002-08-14 US US10/218,554 patent/US7943067B2/en not_active Expired - Fee Related
- 2002-08-15 EP EP02766005A patent/EP1425112B1/en not_active Expired - Lifetime
- 2002-08-15 DE DE60232666T patent/DE60232666D1/en not_active Expired - Lifetime
- 2002-08-15 EP EP02766006.7A patent/EP1511580B1/en not_active Expired - Lifetime
- 2002-08-15 WO PCT/US2002/026056 patent/WO2003015701A2/en not_active Application Discontinuation
- 2002-08-15 WO PCT/US2002/026055 patent/WO2003015936A1/en not_active Application Discontinuation
- 2002-08-15 AU AU2002329761A patent/AU2002329761A1/en not_active Abandoned
- 2002-08-15 AT AT02766005T patent/ATE433744T1/en not_active IP Right Cessation
-
2009
- 2009-11-16 US US12/619,090 patent/US7883648B2/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5464629A (en) | 1993-11-16 | 1995-11-07 | Georgetown University | Method of forming hydrogel particles having a controlled size using liposomes |
US6284375B1 (en) | 1996-10-18 | 2001-09-04 | Tuo Jin | Lipid vesicle system |
Non-Patent Citations (4)
Title |
---|
JIN-CHUL KIM ET AL., J. BIOCHEM, vol. 121, 1997, pages 15 - 19 |
KISER ET AL., NATURE, vol. 394, 1998, pages 459 |
YANG ET AL., J. CHROMOTOGR. B., vol. 707, 1998, pages 131 |
YANG ET AL., MAT. SCI. AND ENG. C., vol. 13, 2000, pages 117 |
Also Published As
Publication number | Publication date |
---|---|
EP1425112B1 (en) | 2009-06-17 |
ATE433744T1 (en) | 2009-07-15 |
US7943067B2 (en) | 2011-05-17 |
AU2002329761A1 (en) | 2003-03-03 |
US20100062054A1 (en) | 2010-03-11 |
DE60232666D1 (en) | 2009-07-30 |
EP1511580B1 (en) | 2015-03-18 |
EP1425112A1 (en) | 2004-06-09 |
US20030044455A1 (en) | 2003-03-06 |
WO2003015701A3 (en) | 2004-12-29 |
EP1511580A2 (en) | 2005-03-09 |
WO2003015936A1 (en) | 2003-02-27 |
US7618565B2 (en) | 2009-11-17 |
EP1511580A4 (en) | 2005-06-08 |
WO2003015701A9 (en) | 2003-04-24 |
US20030035842A1 (en) | 2003-02-20 |
EP1425112A4 (en) | 2005-06-15 |
US7883648B2 (en) | 2011-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7883648B2 (en) | Lipobeads and their production | |
Kazakov et al. | UV-induced gelation on nanometer scale using liposome reactor | |
Liu et al. | Stable polymeric nanoballoons: lyophilization and rehydration of cross-linked liposomes | |
Volodkin et al. | Coating of negatively charged liposomes by polylysine: Drug release study | |
Nardin et al. | Amphiphilic block copolymer nanocontainers as bioreactors | |
Kisak et al. | The vesosome-A multicompartment drug delivery vehicle | |
Bramer et al. | Pharmaceutical applications for catanionic mixtures | |
US6835394B1 (en) | Polymersomes and related encapsulating membranes | |
Kazakov et al. | Liposome-nanogel structures for future pharmaceutical applications | |
Zuraw-Weston et al. | Nanoparticles binding to lipid membranes: from vesicle-based gels to vesicle tubulation and destruction | |
US20140127287A1 (en) | Liposome-encapsulated hydrogels for use in a drug delivery system | |
Petralito et al. | Design and development of PEG-DMA gel-in-liposomes as a new tool for drug delivery | |
Rank et al. | Preparation of monodisperse block copolymer vesicles via a thermotropic cylinder− vesicle transition | |
US20080260833A1 (en) | Drug delivery vehicle containing vesicles in a hydrogel base | |
Kabanov et al. | What happens to negatively charged lipid vesicles upon interacting with polycation species? | |
Cao et al. | Vesicle-based gel via polyelectrolyte-induced adhesion: structure, rheology, and response | |
Hentze et al. | Templating vesicles, microemulsions, and lyotropic mesophases by organic polymerization processes | |
WO2020058892A1 (en) | Deformable liposomes containing micelles | |
KR101935003B1 (en) | Conjugate showing upper critical solution temperature and temperature-responsive liposome prepared by immobilizing this conjugate on the liposome surface | |
WO2012117587A1 (en) | Method for producing lipid structure | |
Sybachin et al. | Electrostatic complexes of liquid and solid liposomes with spherical polycationic brushes | |
Angelini et al. | Kinetic evaluation of the effect of layer by layer deposition of polyelectrolytes on the stability of POPC liposomes | |
Kazakov et al. | Lipobeads as drug delivery systems | |
Pepin-Donat et al. | Lipidic composite vesicles based on poly (NIPAM), chitosan or hyaluronan: behaviour under stresses | |
Cao | AN EXPERIMENTAL STUDY OF LIPID-MEMBRANE BASED STRUCTURE FORMATION AND DEVELOPMENT OF A RESPONSIVE SYSTEM |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG UZ VC VN YU ZA ZM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
COP | Corrected version of pamphlet |
Free format text: PAGES 1/16-16/16, DRAWINGS, REPLACED BY NEW PAGES 1/16-16/16 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002766006 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2002766006 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |